AAPL310.19-0.47 (-0.15%) ▼|ABBV254.72+0.07 (+0.03%) ▲|ABT95.76-0.08 (-0.08%) ▼|ACN139.72-2.42 (-1.70%) ▼|ADBE219.66-1.88 (-0.85%) ▼|AMAT561.93+7.43 (+1.34%) ▲|AMD503.05-13.07 (-2.53%) ▼|AMGN368.61+0.51 (+0.14%) ▲|AMT165.87+0.62 (+0.37%) ▲|AMZN240.88-5.10 (-2.07%) ▼|AVGO386.30+15.52 (+4.19%) ▲|AXP338.92-10.67 (-3.05%) ▼|BA223.74-7.95 (-3.43%) ▼|BAC58.56-1.30 (-2.17%) ▼|BKNG173.40-8.56 (-4.70%) ▼|BLK984.49-24.94 (-2.47%) ▼|BMY57.85-0.13 (-0.22%) ▼|BNY148.74-4.18 (-2.73%) ▼|BRK-B501.99-2.01 (-0.40%) ▼|C137.67-3.10 (-2.20%) ▼|CAT928.79-11.34 (-1.21%) ▼|CL93.54-1.49 (-1.57%) ▼|CMCSA23.64+0.23 (+0.96%) ▲|COF195.82-7.07 (-3.48%) ▼|COP111.02+2.58 (+2.38%) ▲|COST961.47+13.97 (+1.47%) ▲|CRM166.21-3.31 (-1.95%) ▼|CSCO112.84+1.05 (+0.94%) ▲|CVS104.82+0.49 (+0.47%) ▲|CVX177.91+3.90 (+2.24%) ▲|DE593.70-9.92 (-1.64%) ▼|DHR190.92-3.27 (-1.68%) ▼|DIS96.95-0.53 (-0.54%) ▼|DUK128.44+0.22 (+0.17%) ▲|EMR134.38-3.54 (-2.56%) ▼|FDX307.21-5.67 (-1.81%) ▼|GD372.79-1.85 (-0.49%) ▼|GE355.29-11.69 (-3.19%) ▼|GEV1,080.59+3.51 (+0.33%) ▲|GILD135.79-0.57 (-0.42%) ▼|GM75.61-0.42 (-0.55%) ▼|GOOG357.61-6.01 (-1.65%) ▼|GOOGL360.49-6.54 (-1.78%) ▼|GS1,015.78-27.20 (-2.61%) ▼|HD334.42-10.79 (-3.13%) ▼|HON220.51-4.54 (-2.02%) ▼|IBM301.06-5.08 (-1.66%) ▼|INTC105.18-5.21 (-4.72%) ▼|INTU271.62-9.56 (-3.40%) ▼|ISRG416.93-10.38 (-2.43%) ▼|JNJ267.07-0.17 (-0.06%) ▼|JPM332.48-6.75 (-1.99%) ▼|KO84.67+0.62 (+0.74%) ▲|LIN529.47-8.77 (-1.63%) ▼|LLY1,224.80-10.76 (-0.87%) ▼|LMT530.88-4.50 (-0.84%) ▼|LOW213.62-7.28 (-3.30%) ▼|LRCX328.26+2.13 (+0.65%) ▲|MA519.90-11.72 (-2.20%) ▼|MCD278.19-4.02 (-1.42%) ▼|MDLZ59.96-0.26 (-0.43%) ▼|MDT82.19-1.64 (-1.96%) ▼|META603.69-11.89 (-1.93%) ▼|MMM153.79-4.22 (-2.67%) ▼|MO73.76+0.80 (+1.10%) ▲|MRK126.64-2.22 (-1.72%) ▼|MS216.39-5.65 (-2.54%) ▼|MSFT382.58-6.26 (-1.61%) ▼|MU923.00-15.38 (-1.64%) ▼|NEE88.43-0.04 (-0.05%) ▼|NFLX75.92-0.27 (-0.35%) ▼|NKE42.38-0.83 (-1.92%) ▼|NOW106.69-4.04 (-3.65%) ▼|NVDA197.76+0.83 (+0.42%) ▲|ORCL137.98-3.63 (-2.56%) ▼|PEP144.40-0.58 (-0.40%) ▼|PFE24.29+0.22 (+0.91%) ▲|PG149.74-3.01 (-1.97%) ▼|PLTR128.87-5.50 (-4.09%) ▼|PM189.28+1.49 (+0.79%) ▲|QCOM182.46-0.51 (-0.28%) ▼|RTX197.03-3.82 (-1.90%) ▼|SBUX102.92-0.69 (-0.67%) ▼|SCHW102.19+0.26 (+0.26%) ▲|SO97.46+0.17 (+0.17%) ▲|SPG223.73-3.47 (-1.53%) ▼|T21.32+0.23 (+1.07%) ▲|TMO509.84-6.79 (-1.31%) ▼|TMUS183.43-1.30 (-0.70%) ▼|TSLA393.55-9.35 (-2.32%) ▼|TXN300.62+7.32 (+2.49%) ▲|UBER72.69-1.64 (-2.21%) ▼|UNH427.95-0.24 (-0.06%) ▼|UNP281.42-1.71 (-0.60%) ▼|UPS109.46-2.50 (-2.23%) ▼|USB61.05-1.84 (-2.93%) ▼|V348.13-4.08 (-1.16%) ▼|VZ43.02+0.43 (+1.01%) ▲|WFC85.47-1.71 (-1.96%) ▼|WMT113.43+1.89 (+1.69%) ▲|XOM142.63+0.94 (+0.66%) ▲|AAPL310.19-0.47 (-0.15%) ▼|ABBV254.72+0.07 (+0.03%) ▲|ABT95.76-0.08 (-0.08%) ▼|ACN139.72-2.42 (-1.70%) ▼|ADBE219.66-1.88 (-0.85%) ▼|AMAT561.93+7.43 (+1.34%) ▲|AMD503.05-13.07 (-2.53%) ▼|AMGN368.61+0.51 (+0.14%) ▲|AMT165.87+0.62 (+0.37%) ▲|AMZN240.88-5.10 (-2.07%) ▼|AVGO386.30+15.52 (+4.19%) ▲|AXP338.92-10.67 (-3.05%) ▼|BA223.74-7.95 (-3.43%) ▼|BAC58.56-1.30 (-2.17%) ▼|BKNG173.40-8.56 (-4.70%) ▼|BLK984.49-24.94 (-2.47%) ▼|BMY57.85-0.13 (-0.22%) ▼|BNY148.74-4.18 (-2.73%) ▼|BRK-B501.99-2.01 (-0.40%) ▼|C137.67-3.10 (-2.20%) ▼|CAT928.79-11.34 (-1.21%) ▼|CL93.54-1.49 (-1.57%) ▼|CMCSA23.64+0.23 (+0.96%) ▲|COF195.82-7.07 (-3.48%) ▼|COP111.02+2.58 (+2.38%) ▲|COST961.47+13.97 (+1.47%) ▲|CRM166.21-3.31 (-1.95%) ▼|CSCO112.84+1.05 (+0.94%) ▲|CVS104.82+0.49 (+0.47%) ▲|CVX177.91+3.90 (+2.24%) ▲|DE593.70-9.92 (-1.64%) ▼|DHR190.92-3.27 (-1.68%) ▼|DIS96.95-0.53 (-0.54%) ▼|DUK128.44+0.22 (+0.17%) ▲|EMR134.38-3.54 (-2.56%) ▼|FDX307.21-5.67 (-1.81%) ▼|GD372.79-1.85 (-0.49%) ▼|GE355.29-11.69 (-3.19%) ▼|GEV1,080.59+3.51 (+0.33%) ▲|GILD135.79-0.57 (-0.42%) ▼|GM75.61-0.42 (-0.55%) ▼|GOOG357.61-6.01 (-1.65%) ▼|GOOGL360.49-6.54 (-1.78%) ▼|GS1,015.78-27.20 (-2.61%) ▼|HD334.42-10.79 (-3.13%) ▼|HON220.51-4.54 (-2.02%) ▼|IBM301.06-5.08 (-1.66%) ▼|INTC105.18-5.21 (-4.72%) ▼|INTU271.62-9.56 (-3.40%) ▼|ISRG416.93-10.38 (-2.43%) ▼|JNJ267.07-0.17 (-0.06%) ▼|JPM332.48-6.75 (-1.99%) ▼|KO84.67+0.62 (+0.74%) ▲|LIN529.47-8.77 (-1.63%) ▼|LLY1,224.80-10.76 (-0.87%) ▼|LMT530.88-4.50 (-0.84%) ▼|LOW213.62-7.28 (-3.30%) ▼|LRCX328.26+2.13 (+0.65%) ▲|MA519.90-11.72 (-2.20%) ▼|MCD278.19-4.02 (-1.42%) ▼|MDLZ59.96-0.26 (-0.43%) ▼|MDT82.19-1.64 (-1.96%) ▼|META603.69-11.89 (-1.93%) ▼|MMM153.79-4.22 (-2.67%) ▼|MO73.76+0.80 (+1.10%) ▲|MRK126.64-2.22 (-1.72%) ▼|MS216.39-5.65 (-2.54%) ▼|MSFT382.58-6.26 (-1.61%) ▼|MU923.00-15.38 (-1.64%) ▼|NEE88.43-0.04 (-0.05%) ▼|NFLX75.92-0.27 (-0.35%) ▼|NKE42.38-0.83 (-1.92%) ▼|NOW106.69-4.04 (-3.65%) ▼|NVDA197.76+0.83 (+0.42%) ▲|ORCL137.98-3.63 (-2.56%) ▼|PEP144.40-0.58 (-0.40%) ▼|PFE24.29+0.22 (+0.91%) ▲|PG149.74-3.01 (-1.97%) ▼|PLTR128.87-5.50 (-4.09%) ▼|PM189.28+1.49 (+0.79%) ▲|QCOM182.46-0.51 (-0.28%) ▼|RTX197.03-3.82 (-1.90%) ▼|SBUX102.92-0.69 (-0.67%) ▼|SCHW102.19+0.26 (+0.26%) ▲|SO97.46+0.17 (+0.17%) ▲|SPG223.73-3.47 (-1.53%) ▼|T21.32+0.23 (+1.07%) ▲|TMO509.84-6.79 (-1.31%) ▼|TMUS183.43-1.30 (-0.70%) ▼|TSLA393.55-9.35 (-2.32%) ▼|TXN300.62+7.32 (+2.49%) ▲|UBER72.69-1.64 (-2.21%) ▼|UNH427.95-0.24 (-0.06%) ▼|UNP281.42-1.71 (-0.60%) ▼|UPS109.46-2.50 (-2.23%) ▼|USB61.05-1.84 (-2.93%) ▼|V348.13-4.08 (-1.16%) ▼|VZ43.02+0.43 (+1.01%) ▲|WFC85.47-1.71 (-1.96%) ▼|WMT113.43+1.89 (+1.69%) ▲|XOM142.63+0.94 (+0.66%) ▲|
25 C
New York
Wednesday, July 8, 2026

Tag: development

newssourceFORcompanyinformationcontent1releasesmarket

UNIVERSAL MUSIC GROUP N.V. ANNOUNCES RESIGNATION OF CYRILLE BOLLORÉ FROM ITS BOARD OF DIRECTORS

HILVERSUM, Netherlands, July 28, 2025 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) announced that Non-Executive Director Cyrille Bolloré notified the company of his...

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, ‘EYLUXVI® (ALT-L9)’

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea®Upon approval, EYLUXVI® will...

VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced the timing of its second quarter 2025 earnings release and conference call.

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

Basel, 28 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey. 

Windfall Mining Group inc. reaches a new milestone in its development in Quebec

MONTREAL, July 27, 2025 /CNW/ - Windfall Mining Group inc. (WMG), Canadian subsidiary of the global gold group Gold Fields Limited, announces today a...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

PERTH, Australia, July 28, 2025 /PRNewswire/ -- Galan Lithium Limited (ASX: GLN) ("Galan" or "the Company") is pleased to advise that the Comite Evaluador...

Remittix Confirms Q3 2025 Beta Wallet Launch with Solana and Ethereum Support, Presale Surpasses $17.3 Million

KOŠICE, Slovakia, July 26, 2025 (GLOBE NEWSWIRE) -- Remittix (RTX), a crypto payments project focused on practical financial utility, has officially announced the Q3 2025 launch of its beta wallet featuring Solana and Ethereum integration. The news follows strong momentum in its presale phase, which has now exceeded $17.3 million in contributions and 573 million tokens sold.

Coinchange Marks 4 Years of ‘Earn’ Product as Institutional-Grade Yield Infrastructure Expands Globally

Coinchange Celebrates 4 Years of 'Earn' Product, Marks 7 Years of Growth. The Canadian digital asset management platform reflects on its evolution from retail app to institutional-grade yield infrastructure. 
Coinchange Celebrates 4 Years of 'Earn' Product, Marks 7 Years of Growth. The Canadian digital asset management platform reflects on its evolution from retail app to institutional-grade yield infrastructure.

Bitcoin Swift Nears Completion of Stage 1 Presale with $1 Token Price and AI-Powered Rewards System

LUXEMBOURG, July 26, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a next-generation blockchain infrastructure protocol, is approaching the final hours of Stage 1 of its presale, offering early adopters programmable Proof-of-Yield (PoY) rewards and ecosystem access at a fixed entry price of $1.00. The project has drawn attention for launching with built-in staking incentives, AI-driven governance, and a collateral-backed stablecoin—all live from day one.

SOUEAST Unveils New Chapter in Egypt, Strengthening African Market Presence

Cairo, July 24th, 2025—SOUEAST launched four new models in Egypt, marking a significant expansion in the African market.

Bitcoin Swift Presale 2025 Nears Stage 2: Real Utility, AI-Powered Blockchain

LUXEMBOURG, July 26, 2025 (GLOBE NEWSWIRE) -- As investor focus shifts away from large-cap cryptocurrencies with limited upside, early-stage projects with real-world utility and scalable technology are gaining traction. One such project is Bitcoin Swift (BTC3), a next-generation blockchain protocol currently in its presale phase. With a fixed price of $1.00 during Stage 1 and a confirmed $15.00 launch target, Bitcoin Swift is positioning itself as a notable entry in the 2025 crypto landscape.

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase inhibitor candidates –

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers